High Quality Evidence of Chinese Lupus Nephritis (HELP)
ConditionLupus Nephritis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age14+
SponsorSun Yat-sen University
About this trial
The investigators are registering LN patients at recruited hospitals and developing a LN database in China. Patients will be follow-up every year, and both baseline and follow-up information will be entered into the registration system.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients who diagnosis as lupus nephritis
Disqualifiers
No
Trial population
Lupus nephritis patients
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
No Intervention
Other interventionRegistration of all LN patients in the First Affiliated Hospital of Sun Yat-sen University and other hospitals which have signed the contract in China.
Treatment groups
5,000 Participants
are divided into 1 treatment groupGroup A: LN patients1 intervention
Trial outcomes
Primary outcomes
1
All-cause mortality and cardiovascular mortality of LN patients
Time frame
10years2
A composite renal outcome of LN patients
The composite renal outcome defined as doubling of serum creatinine and ESRD (defined as initiation of dialysis or kidney transplantation).
Time frame
10yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov